This inventor holds 8 USPTO granted patents. Top assignees: Spofa, Spojene Podniky Pro Zdravotnickou Vyrobu, Spofa United Pharmaceutical Works, Spojene Podniky Pro Zdravotnickou Vyrobu. Active years: 1980-1997.
Location History:
- Prague, CZ (1980 - 1988)
- Praha, CZ (1993 - 1997)
Company Filing History:
4 out of 16 
2 out of 8 
1 out of 1 Years Active: 1980-1997
Title: Jiri Krepelka: Innovator in Antitumor and Cell-Protective Compounds
Introduction
Jiri Krepelka is a notable inventor based in Prague, Czech Republic. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor compounds and cell-protective compositions. With a total of 8 patents to his name, Krepelka's work has the potential to impact the treatment of various medical conditions.
Latest Patents
Krepelka's latest patents include innovative compounds such as 6-[X-(2-hydroxyethyl)aminoalkyl]-5,11-dioxo-5,6-dihydro-11H-indeno[-1,2-c]isochinoline derivatives. These compounds are represented by a general formula where X indicates the number of carbon atoms in the aminoalkyl group. The antitumor properties of these derivatives are particularly noteworthy, as they are prepared through specific chemical reactions involving indeno[1,2-c]isocoumarine and N-(hydroxyethyl)alkylen diamine in suitable solvents. Additionally, Krepelka has developed a cell-protective composition aimed at preventing or treating peptic ulcers, which is designed for both oral and parenteral administration.
Career Highlights
Throughout his career, Krepelka has worked with several prominent companies in the pharmaceutical industry. Notable among these are Spofa, a leading pharmaceutical manufacturer, and Spofa United Pharmaceutical Works. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Krepelka has collaborated with esteemed colleagues such as Antonin Cerny and Karel Rezabek. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented compounds.
Conclusion
Jiri Krepelka's contributions to the field of pharmaceuticals through his innovative patents demonstrate his commitment to advancing medical science. His work in developing antitumor and cell-protective compounds holds promise for improving treatment options for patients.